DAY 2 ✦ Wed, Apr 28 - All Times are EST

DAY 2 ✦ Wed, Apr 28 9:00am - 10:00am60 mins

Solution Summit Hosted by PwC

DAY 2 ✦ Wed, Apr 28 10:15am - 10:30am15 mins

Day Two Kick-Off — Benchmarking Report Reveal

DAY 2 ✦ Wed, Apr 28 10:30am - 11:00am30 mins

Analysis of OIG Special Fraud Alert on Speaker Programs and Assessment of Future Activities

DAY 2 ✦ Wed, Apr 28 11:00am - 11:30am30 mins

Regulatory Showcase ● FDA Address

Catherine Gray, PharmD - Acting Director, Office of Prescription Drug Promotion (OPDP), U.S. Food and Drug Administration

DAY 2 ✦ Wed, Apr 28 11:30am - 12:00pm30 mins

Regulatory Showcase ● CMS Address

Veronika Peleshchuk Fradlin - Acting Director, Division of Data & Informatics, CMS

DAY 2 ✦ Wed, Apr 28 12:00pm - 1:00pm60 mins

TAKE TIME FOR NETWORKING VIRTUALLY AND VIEWING ON‑DEMAND CONTENT

DAY 2 ✦ Wed, Apr 28 1:00pm - 1:30pm30 mins

Applying Behavioral Science for Impact and to Drive Ethical Culture

Michael Shaw - Principal, Global Head of Risk & Compliance, ZS Associates
Jacob Braude - Principal, Head of Applied Behavioral Insights, ZS Associates

DAY 2 ✦ Wed, Apr 28 1:30pm - 2:30pm60 mins

Former Prosecutor Panel — Answers and Insights from Industry’s Trusted Advisors

Craig Carpenito - U.S. Attorney, U.S. Attorney’s Office for the District of New Jersey
Andrew Lelling - U.S. Attorney, U.S. Attorney’s Office for the District of Massachusetts

DAY 2 ✦ Wed, Apr 28 3:00pm - 4:00pm60 mins

CCO & GC Luminary Panel — Leading Strategies to Advance the Business and Accelerate Innovation

Gregory Moss - Executive Vice President, General Counsel and Corporate Secretary, Chief Compliance Officer, Kadmon
Beth Holly - Senior Vice President, Associate General Counsel & Chief Compliance Officer, Regeneron Pharmaceuticals
Rahul Khara, PharmD - Vice President, Legal and Chief Compliance Officer, Acceleron Pharma Inc.

Compliance and Ethics Roundtable Exchange — Best Practice and Knowledge Sharing Table Talks

DAY 2 ✦ Wed, Apr 28 4:00pm - 5:00pm60 mins

Table Talk A

Speaker Programs

Ernie Hernandez - Chief Compliance Officer, Global Blood Therapeutics
Jeremy Lutsky - Assistant General Counsel, Myovant Sciences, Inc.
Hannah Putnam - Corporate Ethics & Compliance Officer, Fresenius Medical Care North America
Brian Sharkey - Vice President, Teva Pharmaceuticals

DAY 2 ✦ Wed, Apr 28 4:00pm - 5:00pm60 mins

Table Talk B

Insights for Emerging and Newly Commercial Companies

Christie Camelio - Chief Compliance, Ethics & Risk Management Officer, TG Therapeutics
Ed Sleeper - Executive Director, Ethics and Compliance, Esperion — The Lipid Management Company
Amy Wilson - Head of U.S. Compliance, MorphoSys AG

DAY 2 ✦ Wed, Apr 28 4:00pm - 5:00pm60 mins

Table Talk C

Clinical and R&D Compliance